PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
116 hedge funds and large institutions have $164M invested in Paratek Pharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 36 increasing their positions, 33 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
2% less capital invested
Capital invested by funds: $167M → $164M (-$3.09M)
68% less call options, than puts
Call options by funds: $760K | Put options by funds: $2.37M
Holders
116
Holding in Top 10
1
Calls
$760K
Puts
$2.37M
Top Buyers
| 1 | +$1.72M | |
| 2 | +$1.7M | |
| 3 | +$1.18M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$1.12M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$1.07M |
Top Sellers
| 1 | -$3.96M | |
| 2 | -$1.7M | |
| 3 | -$1.2M | |
| 4 |
D.E. Shaw & Co
New York
|
-$748K |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$626K |